Saimaa Generics Private Limited
About Saimaa Generics Private Limited
Data last updated:
Saimaa Generics Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 February 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24230WB2002PTC094308. Its GSTIN is 19AAGCS7418H1Z1 (West Bengal).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹33.73 Lakh. It is led by directors Naveen Khanna and Ritu Khanna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 756A Block P New Alipore, Kolkata, West Bengal, India – 700053.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.18 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹29.91 Lakh (net margin 3.3%) and EBITDA of ₹47.93 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 5% over five years.
As per MCA filings, the company has satisfied charges of ₹1.75 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address756A Block P New Alipore, Kolkata, West Bengal, India – 700053
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Saimaa Generics Private Limited
The main business activity of Saimaa Generics is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Saimaa Generics Private Limited FY 2025 filings available
Saimaa Generics Private Limited reported revenue of ₹9.18 Cr (up 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Saimaa Generics Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 29% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Saimaa Generics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹47.93 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹29.91 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Saimaa Generics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Saimaa Generics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Saimaa Generics Private Limited
Saimaa Generics Private Limited is audited by M JAIN & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M JAIN & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Saimaa Generics Private Limited
Saimaa Generics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naveen Khanna | Director | 28 Feb 2002 | 24 Years 7 Months | Current |
| Ritu Khanna | Director | 28 Feb 2002 | 24 Years 7 Months | Current |
Ownership and Shareholding of Saimaa Generics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Saimaa Generics Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jan 2007 | Union Bank of India | ₹90 Lakh | Satisfied |
| 10 Feb 2003 | Union Bank of India | ₹85 Lakh | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Saimaa Generics Private Limited
Saimaa Generics Private Limited has 1 court case on record: 1 filed by Saimaa Generics. All case is disposed. Status as checked on 29 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Calcutta High Court | Writ petition | Filed by the company against State of West Bengal & Ors | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Saimaa Generics Private Limited
Employment history and EPFO contributions of people linked to Saimaa Generics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Saimaa Generics Private Limited
Saimaa Generics has one previous CIN (Corporate Identification Number): U99999WB2002PTC094308. The current CIN is U24230WB2002PTC094308, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230WB2002PTC094308 | Current |
| U99999WB2002PTC094308 | Previous |
Recent Activity on Saimaa Generics Private Limited
Saimaa Generics Private Limited has 3 board changes on record since 2002: 2 appointments and 1 cessation. The latest: Rabindra Nath Khanna ceased to be Director on 06 Oct 2022.
Credit Ratings, Litigation & Regulatory Alerts for Saimaa Generics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Saimaa Generics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Saimaa Generics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Saimaa Generics Private Limited
Saimaa Generics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAGCS7418H1Z1 | West Bengal | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Saimaa Generics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saimaa Generics Private Limited
Saimaa Generics is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 February 2002 (24+ years old) and is registered under CIN U24230WB2002PTC094308.
Saimaa Generics reported revenue of ₹9.18 Cr for FY 2025 (up 29% YoY).
Saimaa Generics has 2 current directors:
- Naveen Khanna - Director
- Ritu Khanna - Director
Saimaa Generics reported a net profit of ₹29.91 Lakh (net margin 3.3%) and EBITDA of ₹47.93 Lakh (EBITDA margin 5.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Saimaa Generics is 10% over three years and 5% over five years. In the latest year (FY 2025) revenue rose 29%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Saimaa Generics is 19AAGCS7418H1Z1, registered in West Bengal.
The CIN (Corporate Identification Number) of Saimaa Generics is U24230WB2002PTC094308. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saimaa Generics has 1 court case on record: 1 filed by the company.
Saimaa Generics was incorporated on 28 February 2002, making it 24+ years old. It is registered with the Registrar of Companies, Kolkata.
Rabindra Nath Khanna ceased to be Director on 06 Oct 2022. Naveen Khanna was appointed as Director on 28 Feb 2002. Ritu Khanna was appointed as Director on 28 Feb 2002.